Inmunomodulación y Microambiente Tumoral
ITAM
![Foto de Inmunomodulación y Microambiente Tumoral](/img/uploaded/c0b38ccda2541aecc1b9d759d57af663.jpg)
![Foto de Helmholtz Zentrum München](/img/noimage_org.png)
Helmholtz Zentrum München
Múnich, AlemaniaHelmholtz Zentrum München-ko ikertzaileekin lankidetzan egindako argitalpenak (4)
2024
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
2016
-
T-and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates
Gene Therapy, Vol. 23, Núm. 10, pp. 753-759
2008
-
Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model
Journal of Gene Medicine, Vol. 10, Núm. 2, pp. 177-186
2007
-
Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity
Hepatology, Vol. 45, Núm. 3, pp. 602-613